{"id":17665,"date":"2025-06-10T12:01:34","date_gmt":"2025-06-10T16:01:34","guid":{"rendered":"https:\/\/mdbc2.wpenginepowered.com\/product\/crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4\/?courseid="},"modified":"2025-06-10T12:01:34","modified_gmt":"2025-06-10T16:01:34","slug":"crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4","status":"publish","type":"product","link":"https:\/\/www.mdbriefcase.com\/fr\/product\/crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4\/?courseid=","title":{"rendered":"CRC: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in CRC Therapy"},"content":{"rendered":"<p>Recent literature demonstrates that colorectal cancer (CRC) is now the most common type of cancer in the Kingdom of Saudi Arabia (KSA). For people undergoing treatment for CRC, pharmacists will play a pivotal role in their health care team.<\/p>\n<p>The objective of this online program is to help educate and support pharmacists in the KSA in understanding the current landscape of CRC &#8211; genetic aberrations, risk factors, incidence, and selected newly approved therapies. There is also discussion about common adverse events associated with guideline-recommended treatment of CRC, and the role of pharmacists to help mitigate these adverse events in their patients.\n<\/p>\n<hr>\n<p>This program has received an educational grant or in-kind support from Novartis.<\/p>","protected":false},"excerpt":{"rendered":"<p>Recent literature demonstrates that colorectal cancer (CRC) is now the most common type of cancer in the Kingdom of Saudi Arabia (KSA). For people undergoing treatment for CRC, pharmacists will play a pivotal role in their health care team. The objective of this online program is to help educate and support pharmacists in the KSA [&hellip;]<\/p>\n","protected":false},"featured_media":0,"comment_status":"","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"product_brand":[],"product_cat":[],"product_tag":[],"class_list":{"0":"post-17665","1":"product","2":"type-product","3":"status-publish","6":"first","7":"instock","8":"downloadable","9":"virtual","10":"taxable","11":"product-type-simple"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CRC: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in CRC Therapy - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/product\/crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4\/?courseid=\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CRC: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in CRC Therapy - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"Recent literature demonstrates that colorectal cancer (CRC) is now the most common type of cancer in the Kingdom of Saudi Arabia (KSA). For people undergoing treatment for CRC, pharmacists will play a pivotal role in their health care team. The objective of this online program is to help educate and support pharmacists in the KSA [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/product\/crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4\/?courseid=\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/product\\\/crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4\\\/?courseid=\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/product\\\/crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4\\\/?courseid=\",\"name\":\"CRC: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in CRC Therapy - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#website\"},\"datePublished\":\"2025-06-10T16:01:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/product\\\/crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4\\\/?courseid=#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.mdbriefcase.com\\\/product\\\/crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4\\\/?courseid=\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/product\\\/crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4\\\/?courseid=#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop &#8211; Old\",\"item\":\"https:\\\/\\\/www.mdbriefcase.com\\\/shop\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CRC: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in CRC Therapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#website\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.mdbriefcase.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/logo.webp\",\"contentUrl\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CRC: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in CRC Therapy - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/product\/crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4\/?courseid=","og_locale":"fr_CA","og_type":"article","og_title":"CRC: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in CRC Therapy - MDBriefCase","og_description":"Recent literature demonstrates that colorectal cancer (CRC) is now the most common type of cancer in the Kingdom of Saudi Arabia (KSA). For people undergoing treatment for CRC, pharmacists will play a pivotal role in their health care team. The objective of this online program is to help educate and support pharmacists in the KSA [&hellip;]","og_url":"https:\/\/www.mdbriefcase.com\/fr\/product\/crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4\/?courseid=","og_site_name":"MDBriefCase","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/product\/crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4\/?courseid=","url":"https:\/\/www.mdbriefcase.com\/product\/crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4\/?courseid=","name":"CRC: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in CRC Therapy - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"datePublished":"2025-06-10T16:01:34+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/product\/crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4\/?courseid=#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/product\/crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4\/?courseid="]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/product\/crc-risk-factors-newly-approved-therapies-and-the-role-of-the-pharmacist-in-crc-therapy-4\/?courseid=#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Shop &#8211; Old","item":"https:\/\/www.mdbriefcase.com\/shop\/"},{"@type":"ListItem","position":3,"name":"CRC: Risk Factors, Newly Approved Therapies and the Role of the Pharmacist in CRC Therapy"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product\/17665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=17665"}],"wp:attachment":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=17665"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product_brand?post=17665"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product_cat?post=17665"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/product_tag?post=17665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}